Advertisement

#IDWeek 2020

AstraZeneva COVID-19 vaccine production

Third COVID-19 Vaccine May Be Up to 90% Effective

The vaccine from the University of Oxford and AstraZeneca uses a chimpanzee adenovirus vector.

Bictegravir and Dolutegravir Tied to Metabolic Side Effects

These two integrase inhibitors are associated with high blood sugar and diabetes.

Study Sheds Light on Weight Gain After Switching to New Tenofovir

This may reflect loss of the weight-suppressing effect of the older version of the drug.

People Prefer Injectable Cabenuva After Switching From Oral Meds

After years of taking daily oral cabotegravir and Edurant, people with suppressed HIV switched to long-acting injectable Cabenuva.

Switching to Biktarvy Is a Success for African Americans With HIV

Black study participants switched from a regimen with two nucleoside/nucleotide reverse transcriptase inhibitors plus one other HIV drug.

Antibodies binding to protein

Trogarzo Maintains Viral Load Suppression for Nearly 10 Years

Extended follow-up confirms that the long-acting monoclonal antibody works well for people with highly resistant HIV.

Advertisement